Solute Carrier Organic Anion Transporter Family Member 1B1 (SLCO1B1) Genotype, Statin, Saliva
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Aiding prediction of risk for statin-associated myopathy for patients beginning statin therapy, especially simvastatin therapy
Determining a potential genetic effect related to statin intolerance in patients with statin-associated myopathy, especially related to simvastatin
Assessing the SLCO1B1 *5 genotype in patients who received a blood transfusion or bone marrow transplant in the preceding 45 days (6 weeks)
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR) 5’-Nuclease End-Point Allelic Discrimination Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
SLCO1B1 Genotype, Statin, Saliva